NC

Numoda Capital Innovations

North America, Pennsylvania, United States, Philadelphia

Description

Numoda Capital Innovations is an investment firm.

Investor Profile

Numoda Capital Innovations has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Medical, Pharmaceutical, Health Care.

Stage Focus

  • Series C (67%)
  • Series B (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Medical
  • Pharmaceutical
  • Health Care
  • Biotechnology
  • Biopharma
  • Women's
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Numoda Capital Innovations frequently co-invest with?

RUSNANO
North America, California, United States, Menlo Park
Co-Investments: 1
Domain Associates
North America, California, United States, San Diego
Co-Investments: 2
RMI Partners
Europe, Moscow City, Russian Federation, Moscow
Co-Investments: 1
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 2
Burrill & Company
North America, California, United States, San Francisco
Co-Investments: 1
R
Europe, Moscow City, Russian Federation, Moscow
Co-Investments: 1
AMOREPACIFIC Ventures
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2

What are some of recent deals done by Numoda Capital Innovations?

Evofem Biosciences

San Diego, California, United States

Evofem is a biopharmaceutical company that offers women reproductive and contraceptive care products.

BiopharmaHealth CareMedicalWomen's
Series CDec 19, 2012
Amount Raised: $20,600,000
Neothetics

San Diego, California, United States

Neothetics is a clinical-stage specialty pharmaceutical company that develops therapeutics for the aesthetic market.

Health CarePharmaceuticalTherapeutics
Series CDec 19, 2012
Amount Raised: $20,600,000
MabVax Therapeutics

San Diego, California, United States

MabVax is a biopharmaceutical company focused on the commercialization of proprietary anti-cancer immunotherapies.

BiotechnologyMedicalPharmaceutical
Series BNov 20, 2012
Amount Raised: $5,250,000

Find More Investors Like Numoda Capital Innovations

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Numoda Capital Innovations | Pipeseed